Gilead Sciences, Inc.

Gilead Sciences, Inc.verified

GILD

Price:

$65.68

Market Cap:

$81.83B

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1992-01-22

Stock Exchange

NASDAQ

Ticker

GILD

The PE Ratio as of May 2024 (TTM) for Gilead Sciences, Inc. (GILD) is 182.44

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 182.44. This represents a change of 1.49% compared to the average of 11.50 of the last 4 quarters.

Gilead Sciences, Inc. (GILD) Historical PE Ratio (quarterly & annually)

How has GILD PE Ratio performed in the past?

The mean historical PE Ratio of Gilead Sciences, Inc. over the last ten years is 95.64. The current 182.44 PE Ratio has changed 18.98% with respect to the historical average. Over the past ten years (40 quarters), GILD's PE Ratio was at its highest in in the December 2018 quarter at 6.72K. The PE Ratio was at its lowest in in the September 2019 quarter at -17.22.

Quarterly (TTM)
Annual

Average

95.64

Median

15.10

Minimum

7.10

Maximum

822.84

Gilead Sciences, Inc. (GILD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.27%

Maximum Annual PE Ratio = 822.84

Minimum Annual Increase = -98.22%

Minimum Annual PE Ratio = 7.10

Quarterly (TTM)
Annual
YearPE RatioChange
202317.85-23.94%
202223.4660.15%
202114.65-98.22%
2020822.845.27%
201915.322.95%
201814.88-26.44%
201720.23184.87%
20167.10-13.19%
20158.18-30.99%
201411.86-68.25%

Gilead Sciences, Inc. (GILD) Average PE Ratio

How has GILD PE Ratio performed in the past?

The current PE Ratio of Gilead Sciences, Inc. (GILD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

18.65

5-year avg

178.82

10-year avg

95.64

Gilead Sciences, Inc. (GILD) PE Ratio vs. Peers

How is GILD’s PE Ratio compared to its peers?

Gilead Sciences, Inc.’s PE Ratio is greater than Amgen Inc. (43.56), greater than Merck & Co., Inc. (142.24), greater than AbbVie Inc. (46.36), greater than Johnson & Johnson (9.20), greater than Bristol-Myers Squibb Company (-13.57), greater than Pfizer Inc. (-551.94), greater than Eli Lilly and Company (118.49), greater than AstraZeneca PLC (38.43),

CompanyPE RatioMarket cap
43.56$164.06B
142.24$327.97B
46.36$277.35B
9.20$353.71B
-13.57$83.60B
-551.94$163.65B
118.49$767.39B
38.43$243.51B

Build a custom stock screener for Gilead Sciences, Inc. (GILD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GILD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Gilead Sciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Gilead Sciences, Inc. (GILD)?

What is the highest PE Ratio for Gilead Sciences, Inc. (GILD)?

What is the 3-year average PE Ratio for Gilead Sciences, Inc. (GILD)?

What is the 5-year average PE Ratio for Gilead Sciences, Inc. (GILD)?

How does the current PE Ratio for Gilead Sciences, Inc. (GILD) compare to its historical average?